Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

Sabrina Martyr, MD, Arun Balakumuran, MD, PhD, Aldemar Montero, MD, Cynthia E. Dunbar, MD, Elizabeth M. Kang, MD, Phillip Scheinberg, MD, Barbara Weinstein, RN, Xin Tian, Ph.D., Neal S. Young, MD, Adrian Wiestner, MD, PhD

Blood (2013) 122 (21): 2479.

https://doi.org/10.1182/blood.V122.21.2479.2479

Published: 2013

Journal Articles

T-Cell Depleted PBSCT Mitigates Acute GVHD, but Preserves Protective Chronic GVHD. Long Term Follow up of 138 Patients.

Aldemar Montero, MD, Bipin N. Savani, MD, Stephan Mielke, MD, Scott R. Solomon, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 140.

https://doi.org/10.1182/blood.V106.11.140.140

Published: 2005

Journal Articles

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Bipin N. Savani, MD, Ramaprasad Srinivasan, MD, PhD, Aldemar Montero, MD, Anurag Singh, MD, Aarthi Shenoy, MD, Shervin Kamipour, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1116.

https://doi.org/10.1182/blood.V106.11.1116.1116

Published: 2005

Journal Articles

Transplant Outcome in Acute Myeloid but Not Acute Lymphocytic Leukemia Following T Cell Depleted Allogeneic Stem Cell Transplantation May Be Favorably Influenced by Early Recovery of NK Cells.

Bipin N. Savani, MD, Aldemar Montero, MD, Stephan Mielke, MD, Katayoun Rezvani, MD, Aarthi Shenoy, MD, Richard Childs, MD, A. John Barrett, MD

Blood (2005) 106 (11): 1405.

https://doi.org/10.1182/blood.V106.11.1405.1405

Published: 2005

Journal Articles

Favorable Impact of T Cell Depleted PBSCT on Transplant Outcomes Despite Delayed Donor T Cell Engraftment.

Aldemar Montero, MD, Roger Kurlander, MD, Elizabeth Read, MD, Susan Leitman, MD, Nene Nlonda, Neal Young, MD, Richard Childs, MD, Scott Solomon, MD, John Barrett, MD

Blood (2004) 104 (11): 182.

https://doi.org/10.1182/blood.V104.11.182.182

Published: 2004

NARROW

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

T-Cell Depleted PBSCT Mitigates Acute GVHD, but Preserves Protective Chronic GVHD. Long Term Follow up of 138 Patients.

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Transplant Outcome in Acute Myeloid but Not Acute Lymphocytic Leukemia Following T Cell Depleted Allogeneic Stem Cell Transplantation May Be Favorably Influenced by Early Recovery of NK Cells.

Favorable Impact of T Cell Depleted PBSCT on Transplant Outcomes Despite Delayed Donor T Cell Engraftment.

Email alerts

ASH Publications

American Society of Hematology

A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia

T-Cell Depleted PBSCT Mitigates Acute GVHD, but Preserves Protective Chronic GVHD. Long Term Follow up of 138 Patients.

Pulmonary Function Abnormalities 5 Years or More Following Myeloablative and Non-Myeloablative Allogeneic Stem Cell Transplantation for Hematological Disorders - Impact of Chronic GVHD.

Transplant Outcome in Acute Myeloid but Not Acute Lymphocytic Leukemia Following T Cell Depleted Allogeneic Stem Cell Transplantation May Be Favorably Influenced by Early Recovery of NK Cells.

Favorable Impact of T Cell Depleted PBSCT on Transplant Outcomes Despite Delayed Donor T Cell Engraftment.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only